Skip to Main Content

Paper Details

Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).
Int J Cancer
24
2022
Author NameAffiliation
Gerhardt AttardUCL Cancer Institute, University College London
Peter HoskinMount Vernon Cancer Centre
  • 1 - 2

Datasets

Release 1.2